TNFα antagonist therapy in axial spondyloarthritis: Can we do better?

被引：7
|
作者：
Prati, Clement [1 ]
Claudepierre, Pascal [2 ]
Goupille, Philippe [3 ]
Thao Pham [4 ]
Wendling, Daniel [1 ]
机构：
[1] Univ Franche Comte, CHRU Besancon, Serv Rhumatol, Blvd Fleming, F-25030 Besancon, France
[2] Univ Paris Est Creteil, Hop Henri Mondor Creteil, AP HP, Serv Rhumatol,EA EpiDermE, F-94000 Creteil, France
[3] Univ Tours, CHU Tours, CNRS, Serv Rhumatol,UMR 7292, F-37000 Tours, France
[4] Aix Marseille Univ, CHU St Marguerite, AP HM, Serv Rhumatol, F-13000 Marseille, France
来源：
JOINT BONE SPINE | 2016年 / 83卷 / 03期
关键词：
Spondyloarthritis; Treatment; TNF alpha antagonists; Immunogenicity; ANKYLOSING-SPONDYLITIS; RHEUMATOLOGY SFR; FRENCH SOCIETY; INFLIXIMAB; DISEASE; ADALIMUMAB; EFFICACY; RECOMMENDATIONS; IMMUNOGENICITY; MULTICENTER;
D O I：
10.1016/j.jbspin.2016.01.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：247 / 249
页数：3
相关论文
共 50 条
  • [1] Optimizing TNFα antagonist therapy in patients with spondyloarthritis: Why and how?
    Wendling, Daniel
    Prati, Clement
    Goupille, Philippe
    Mulleman, Denis
    JOINT BONE SPINE, 2011, 78 (03) : 225 - 227
  • [2] Withdrawal of biologic therapy in axial spondyloarthritis: the experience in established disease
    Baraliakos, X.
    Kiltz, U.
    Heldmann, F.
    Sieper, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : S43 - S46
  • [3] Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study
    Fagerli, Karen M.
    van der Heijde, Desiree
    Heiberg, Marte S.
    Wierod, Ada
    Kalstad, Synove
    Rodevand, Erik
    Mikkelsen, Knut
    Kvien, Tore K.
    Lie, Elisabeth
    RHEUMATOLOGY, 2014, 53 (06) : 1087 - 1094
  • [4] Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
    Hernandez-Breijo, Borja
    Plasencia-Rodriguez, Chamaida
    Navarro-Compan, Victoria
    Martinez-Feito, Ana
    Jochems, Andrea
    Kneepkens, Eva L.
    Wolbink, Gerrit J.
    Rispens, Theo
    Diego, Cristina
    Pascual-Salcedo, Dora
    Balsa, Alejandro
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [5] Twenty years of clinical trials in axial spondyloarthritis: what can we learn for the future?
    Sieper, Joachim
    Poddubnyy, Denis
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (04) : 363 - 369
  • [6] The prevalence and clinical effect of immunogenicity of TNF-α blockers in patients with axial spondyloarthritis
    Bornstein, G.
    Lidar, M.
    Langevitz, P.
    Fardman, A.
    Ben-Zvi, I.
    Grossman, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (02) : 228 - 232
  • [7] Efficacy of TNF blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis
    Callhoff, Johanna
    Sieper, Joachim
    Weiss, Anja
    Zink, Angela
    Listing, Joachim
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1241 - 1248
  • [8] Drug Levels and Antibodies Against TNF-blockers in Spondyloarthritis and Rheumatoid Arthritis are Associated with the Activity but they do Not Predict it
    Marcela Padilla-Martinez, Erika
    Romero-Sanchez, Consuelo
    Manuel Bello-Gualtero, Juan
    Maria Mesa-Betancourt, Ana
    Bautista-Molano, Wilson
    Valle-O, Rafael
    CURRENT RHEUMATOLOGY REVIEWS, 2019, 15 (04) : 329 - 335
  • [9] Can we consider a pre-clinical state of axial spondyloarthritis?
    Wendling, Daniel
    Goupille, Philippe
    Verhoeven, Frank
    Prati, Clement
    JOINT BONE SPINE, 2024, 91 (04)
  • [10] Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis
    Gratacos, Jordi
    Pontes, Caridad
    Juanola, Xavier
    Sanz, Jesus
    Torres, Ferran
    Avendano, Cristina
    Vallano, Antoni
    Calvo, Gonzalo
    de Miguel, Eugenio
    Sanmarti, Raimon
    Almirall, Miriam
    Aparicio, Maria
    Sellas, Agusti
    Vives, Roser
    Albinana, Nestor
    Moreno, Mireia
    Clavaguera, Teresa
    Carlos Torre-Alonso, Juan
    Veroz, Raul
    Rodriguez-Lozano, Carlos
    Francisco Linares, Luis
    Urruticoechea, Ana
    Collantes, Eduardo
    Maria Morla, Rosa
    Reina, Delia
    Cuende, Eduardo
    Zarco, Pedro
    Cruz Fernandez-Espartero, Maria
    Garcia-Vicuna, Rosario
    Alberto Montilla, Carlos
    Villalba, Alejandro
    Pascual, Dora
    Campos, Cristina
    Juan, Antonio
    Ariza, Rafael
    Diaz-Miguel, Consuelo
    Maqueda, Manuel
    Pilar Fernandez-Dapica, Maria
    Fernandez-Prada, Manuel
    Batlle, Enrique
    Gonzalez-Fernandez, Carlos
    Queiro, Ruben
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
12345